|
 |
 |
||||||||||
|
|||||||||||
 |
 |
1. Ontak Approved to Treat T-Cell Lymphoma - US News and World Report
FRIDAY, Oct. 17 (HealthDay News) -- The Eisai Corp. drug Ontak (denileukin diftitox) has been approved to treat cutaneous T-cell lymphoma (CTCL) whose cells contain a certain receptor known as IL2. A receptor is a molecule found on the surface of ce...
2. Incidence of Mantle Cell Lymphoma on Rise - US News and World Report
FRIDAY, July 18 (HealthDay News) -- The prevalence of mantle cell lymphoma, an aggressive form of non-Hodgkin lymphoma, is increasing, and most patients are diagnosed with advanced stages of the disease, notes a study by researchers at the Universit... Expand your search to include all of U.S. News
3. Cutaneous T-Cell Lymphoma
Detailed information on cutaneous T-cell lymphoma, including symptoms, diagnosis, and treatment /> Home. Cutaneous T-cell lymphoma is a disease caused when ... http://www.lancastergeneral.org/content/greystone_36133.htm
4. What is cutaneous T-cell lymphoma.
Cutaneous T-cell lymphoma is a disease caused when T-lymphocytes become malignant and affect the skin. What is cutaneous T-cell lymphoma. What are the sympt... http://www.bestcare.org/Applications/Greystone/?PageID=P07175
5. Cutaneous T-Cell Lymphomas
Non-Hodgkin s lymphomas, such as CTCLs, may also be categorized based upon certain characteristics of the cancer cells as seen under a microscope and how qu... http://headtotoe.apta.org/nord/nord1124.htm |
advertisement |
- Subscriber Services |
- Site Map |
- About Us |
- Contact Us |
- Classroom Program |
- Marketplace |
- Store |
- Advertise With Us |
- Masthead
Use of this Web site constitutes acceptance of our Terms and Conditions of Use and Privacy Policy.